Successful treatment of refractory ascites in a patient with liver cirrhosis combined with hepatic artery-portal vein malformation: A case report

Zhenyu Ge,Kai Wang,Zhaomei Zhang,Xiaoqian Zhang,Peng Sun,Ning Chen,Yang Tan,Tingting Shen,Hongsheng Dai,Wenwen Li
DOI: https://doi.org/10.1097/md.0000000000036886
IF: 1.6
2024-02-03
Medicine
Abstract:Arteriovenous fistulae (AVFs) can develop as a result of the formation of abnormal short channels that link veins and arteries without passage through the capillary network. Hepatic AVFs present as malformed vascular masses resulting from the aberrant anastomosis of hepatic arteries and hepatic veins or portal veins. AVFs incidence rates in the clinic are relatively low, but a growing number of studies have focused on these malformations in recent years owing to advances in diagnostic imaging techniques such as digital subtraction angiography. Clinical research has demonstrated that hepatic AVFs can significantly influence the efficacy of treatment efforts for hepatocellular carcinoma (HCC) and other hepatic diseases. These AVFs can include hepatic arterial-portal fistulae, hepatic arterial-hepatic venous fistulae, and combined hepatic AVFs. Liver AVFs incidence in patients with liver disease (primarily HCC and liver cirrhosis) is estimated to be approximately 4.3%. [ 1 ] Hepatic AVFs formation may be idiopathic or secondary, with the latter accounting for 75% of all cases, [ 2 ] with these malformations being secondary to liver diseases such as HCC or cirrhosis, or to various forms of trauma, infection, puncture biopsy, or surgery.
medicine, general & internal
What problem does this paper attempt to address?